Enrolling by invitationNot applicableNCT07168824

An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on Cognition

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chi-Chang Huang
Principal Investigator
Chi-Chang Huang, PhD
National Taiwan Sport University
Intervention
Lacticaseibacillus paracasei(dietary_supplement)
Enrollment
40 enrolled
Eligibility
50-85 years · All sexes
Timeline
2025 – 2026

Study locations (1)

Collaborators

Bened Biomedical Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07168824 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials